Nuvilex Inc  

(Public, OTCMKTS:NVLX)   Watch this stock  
Find more results for PINK:NVLX
0.349
+0.074 (26.91%)
After Hours: 0.350 0.000 (0.00%)
Apr 17, 4:02PM EDT  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.28 - 0.37
52 week 0.02 - 0.62
Open 0.28
Vol / Avg. 12.43M/8.89M
Mkt cap 222.76M
P/E     -
Div/yield     -
EPS -0.02
Shares 638.28M
Beta 0.22
Inst. own 0%

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin - -13142.27%
Operating margin - -11893.75%
EBITD margin - -13851.73%
Return on average assets -35.88% -64.38%
Return on average equity -41.89% -
Employees 4 -
CDP Score - -

Address

Meadows Corporate Park I, Suite #310, 12
SILVER SPRING, MD 20904-1643
United States - Map
+1-877-5987616 (Phone)
+1-917-5952850 (Fax)

Website links

Description

Nuvilex, Inc. operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation. It is focused on preparations for a new pancreatic cancer clinical trial through live-cell encapsulation of chemotherapeutic-converting cells. It has created the hardware and operating platform to envelop or encapsulate its own or other company's software products, or cells. These cells are then packaged in its live cell encapsulation operating system. Its products include Cinnechol, Cinnergen, Cinnsational, Citroxin, Cyclosurface, Cosmetics, Infinitink, Talsyn, Oraphyte and PurEffect. On July 10, 2013, the Company acquired Bio Blue Bird AG. In November 2013, the Company announced that it has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the development of treatments for diabetes from SG Austria Pte. Ltd.

Officers and directors

Patricia Gruden Interim Chairwoman of the Board, Interim Chief Financial Officer, Interim Secretary
Age: 72
Kenneth L. Waggoner President, Chief Executive Officer
Age: 63
Robert Bowker President of Knock-Out Technologies, Inc; Director
Age: 64
Richard M. Goldfarb M.D. President of MedElite Inc; Director
Age: 59
Timothy Matula President, Chief Executive Officer of Medical Marijuana Sciences,Inc., Director
Age: 50
Gerald W. Crabtree Ph.D. Chief Operating Officer, Director
Age: 73
Robert F. Ryan Ph.D. Chief Science Officer, Director
Age: 53